Local Dystrophin Restoration with Antisense Oligonucleotide PR0051VAN DEUTEKOM, Judith C; JANSON, Anneke A; DE KIMPE, Sjef J et al.The New England journal of medicine. 2007, Vol 357, Num 26, pp 2677-2686, issn 0028-4793, 10 p.Article

Poly(L-lysine)-modified silica nanoparticles for the delivery of antisense oligonucleotidesZHU, Shi-Guo; XIANG, Juan-Juan; KE TANG et al.Biotechnology and applied biochemistry. 2004, Vol 39, pp 179-187, issn 0885-4513, 9 p., 2Article

The characterization of cationic fusogenic liposomes mediated antisense oligonucleotides into HeLa cellsYING HU; YI JIN; YUN XIA et al.Drug development and industrial pharmacy. 2004, Vol 30, Num 2, pp 135-141, issn 0363-9045, 7 p.Article

Local Dystrophin Restoration with Antisense Oligonucleotide PR0051PLAISIER, Emmanuelle; GRIBOUVAL, Olivier; DRACON, Michel et al.The New England journal of medicine. 2007, Vol 357, Num 26, pp 2687-2695, issn 0028-4793, 9 p.Article

An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitisMINER, P. JR; WEDEL, M; BANE, B et al.Alimentary pharmacology & therapeutics. 2004, Vol 19, Num 3, pp 281-286, issn 0269-2813, 6 p.Article

Du gène au comportement, un cheminement nouveau pour l'élaboration de nouveaux agents neuropsychotropes. Discussion : Médicaments psychotropes et Société = From gene to behaviour, a new way for elaborating new neuropsychotropic agents. DiscussionCOSTENTIN, J; ADOLPHE, M; GIROUD, J.-P et al.Bulletin de l'Académie nationale de médecine. 1997, Vol 181, Num 6, pp 1057-1071, issn 0001-4079Article

Smart delivery of antisense oligonucleotides by anionic pH-sensitive liposomesFATTAL, Elias; COUVREUR, Patrick; DUBERNET, Catherine et al.Advanced drug delivery reviews. 2004, Vol 56, Num 7, pp 931-946, issn 0169-409X, 16 p.Article

Novel photoresponsive cross-linking oligodeoxyribonucleotides having a caged α-chloroaldehydeKOBORI, Akio; YAMAUCHI, Takemune; NAGAE, Yuko et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 17, pp 5071-5076, issn 0968-0896, 6 p.Article

Targeting of antisense PNA oligomers to human galanin receptor type 1 mRNAKILK, Kalle; ELMQUIST, Anna; SAAR, Külliki et al.Neuropeptides (Edinburgh). 2004, Vol 38, Num 5, pp 316-324, issn 0143-4179, 9 p.Article

Une classe de molécules attractives : les oligonucléotides thérapeutiquesFICHOU, Y; FEREC, C.Biofutur (Puteaux). 2007, Num 278, pp 36-39, issn 0294-3506, 4 p.Article

Displacement chromatography of anti-sense oligonucleotide and proteins using saccharin as a non-toxic displacerTUGCU, Nihal; DESHMUKH, Ranjit R; SANGHVI, Yogesh S et al.Reactive & functional polymers. 2003, Vol 54, Num 1-3, pp 37-47, issn 1381-5148, 11 p.Article

Locked nucleic acid (LNA) recognition of RNA: NMR solution structures of LNA :RNA hybridsPETERSEN, Michael; BONDENSGAARD, Kent; WENGEL, Jesper et al.Journal of the American Chemical Society. 2002, Vol 124, Num 21, pp 5974-5982, issn 0002-7863Article

Effect of hepatocyte growth factor on early human haemopoietic cell developmentRATAJCZAK, M. Z; MARLICZ, W; RATAJCZAK, J et al.British journal of haematology. 1997, Vol 99, Num 1, pp 228-236, issn 0007-1048Article

A Prospective Study in the Rational Design of Efficient Antisense Oligonucleotides for Exon Skipping in the DMD GeneALOYSIUS DWI PRAMONO, Zacharias; KENG BOON WEE; JIAN LI WANG et al.Human gene therapy. 2012, Vol 23, Num 7, pp 781-790, issn 1043-0342, 10 p.Article

A simple γ-backbone modification preorganizes peptide nucleic acid into a helical structureDRAGULESCU-ANDRASI, Anca; RAPIREDDY, Srinivas; FREZZA, Brian M et al.Journal of the American Chemical Society. 2006, Vol 128, Num 31, pp 10258-10267, issn 0002-7863, 10 p.Article

Multigene targeting with antisense oligodeoxynucleotides : An exploratory study using primary human leukemia cellsOPALINSKA, Joanna B; MACHALINSKI, Boguslaw; RATAJCZAK, Janina et al.Clinical cancer research. 2005, Vol 11, Num 13, pp 4948-4954, issn 1078-0432, 7 p.Article

Scalable membrane ion-exchange chromatography purification of an antisense oligonucleotideLAJMI, Ajay R.Pharmaceutical technology (2003). 2005, Vol 29, Num 5, pp 58-64, issn 1543-2521, 4 p.Article

The inhibition of angiogenesis by antisense oligonucleotides to clusterinJACKSON, John K; GLEAVE, Martin E; GLEAVE, Jacqueline et al.Angiogenesis (London). 2005, Vol 8, Num 3, pp 229-238, issn 0969-6970, 10 p.Article

Antisense oligonucleotidesKASHIHARA, N; MAESHIMA, Y; MAKINO, H et al.Experimental nephrology. 1998, Vol 6, Num 1, pp 84-88, issn 1018-7782Article

Activating the synthesis of progerin, the mutant prelamin A in Hutchinson―Gilford progeria syndrome, with antisense oligonucleotidesFONG, Loren G; VICKERS, Timothy A; DAVIES, Brandon S. J et al.Human molecular genetics (Print). 2009, Vol 18, Num 13, pp 2462-2471, issn 0964-6906, 10 p.Article

Type II/III Runx2/Cbfal is required for tooth germ developmentKOBAYASHI, Ieyoshi; KIYOSHIMA, Tamotsu; WADA, Hiroko et al.Bone (New York, NY). 2006, Vol 38, Num 6, pp 836-844, issn 8756-3282, 9 p.Article

Use of a chemically modified antisense oligonucleotide library to identify and validate Eg5 (kinesin-like 1) as a target for antineoplastic drug developmentROLLER, Erich; PROPP, Stephanie; GLAZER, Robert I et al.Cancer research (Baltimore). 2006, Vol 66, Num 4, pp 2059-2066, issn 0008-5472, 8 p.Article

Cellular penetration and antisense activity by a phenoxazine-substituted heptanucleotideFLANAGAN, W. M; WAGNER, R. W; GRANT, D et al.Nature biotechnology. 1999, Vol 17, Num 1, pp 48-52, issn 1087-0156Article

Oligonucleotide uptake in cultured keratinocytes: Influence of confluence, cationic liposomes, and keratinocyte cell typeWHITE, P. J; FOGARTY, R. D; MCKEAN, S. C et al.Journal of investigative dermatology. 1999, Vol 112, Num 5, pp 699-705, issn 0022-202XArticle

Antisense oligonucleotides as a powerful molecular strategy for gene therapy in cardiovascular diseases : AntisenseTOMITA, N; MORISHITA, R.Current pharmaceutical design. 2004, Vol 10, Num 7, pp 797-803, issn 1381-6128, 7 p.Article